| HOME >> BIOLOGY >> TECHNOLOGY |
According to Patrick Lindsay, Executive Vice President of UBC, "ClinResearch's leadership in adaptive design is consistent with UBC's focus on innovative solutions for clinical development. Reinhard Eisebitt, ClinResearch's co-founder, is recognized by the FDA and European regulatory authorities as a thought leader in adaptive design based on the proprietary software and techniques that he helped develop. We look forward to bringing our combined strengths in this novel and quickly evolving methodology to the industry." The ClinResearch announcement is the latest in a series of transactions made since UBC raised $153 million in equity capital from a syndicate of leading private equity firms in 2003.
Since 1999, ClinResearch, GmbH, headquartered in Cologne, Germany, has been a leader in planning, conducting and reporting clinical studies for the pharmaceutical and medical device industries. For more information, visit http://www.clinresearch.com.
United BioSource Corporation (UBC) is a global pharmaceutical services organization that helps emerging and established life science companies develop and commercialize medical products. UBC specializes in offering new and innovative ways to study drugs and devices by offering expertise in science, strategy and execution.
UBC is headquartered in Bethesda, Maryland, with offices in the United States, Canada, Europe and South America. For more information, visit http://www.unitedbiosource.com or call 866-458-1096.
CONTACT: Tess Drahzal, +1 (240) 644-0420, info@unitedbiosource.com
| SOURCE United BioSource Corporation Copyright©2007 PR Newswire. All rights reserved |